BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8532621)

  • 21. Amniotic fluid analysis in prenatal diagnosis of neural tube defects: a comparison between six biochemical tests supplementary to the measurement of amniotic fluid alpha-fetoprotein.
    Toftager-Larsen K; Wandrup J; Nørgaard-Pedersen B
    Clin Genet; 1984 Nov; 26(5):406-13. PubMed ID: 6209039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human chorionic gonadotrophin and alpha-fetoprotein levels in matched samples of amniotic fluid, extraembryonic coelomic fluid, and maternal serum in the first trimester of pregnancy.
    Wathen NC; Cass PL; Kitau MJ; Chard T
    Prenat Diagn; 1991 Mar; 11(3):145-51. PubMed ID: 1710066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated levels of amniotic fluid alpha-fetoprotein: sonographic evaluation.
    Robbin M; Filly RA; Fell S; Goldstein RB; Callen PW; Goldberg JD; Golbus MS
    Radiology; 1993 Jul; 188(1):165-9. PubMed ID: 7685529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of cholinesterase and acetylcholinesterase in amniotic fluid. Uses in prenatal diagnosis and quality control.
    Elejalde BR; Peck G; de Elejalde MM
    Clin Genet; 1986 Mar; 29(3):196-203. PubMed ID: 2421950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.
    Lancet; 1979 Sep; 2(8144):651-62. PubMed ID: 90757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective prenatal screening for fetal abnormalities using a quantitative immunoassay for acetylcholinesterase.
    Brock DJ; Barron L
    J Med Genet; 1988 Sep; 25(9):606-8. PubMed ID: 2460626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amniotic fluid acetylcholinesterase in the prenatal diagnosis of open neural tube defects and abdominal wall defects: a comparison of gel electrophoresis and a monoclonal antibody immunoassay.
    Rasmussen Loft AG; Nanchahal K; Cuckle HS; Wald NJ; Hulten M; Leedham P; Nørgaard-Pedersen B
    Prenat Diagn; 1990 Jul; 10(7):449-59. PubMed ID: 2146603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylcholinesterase in human amniotic fluid: An index of fetal neural development?
    Chubb IW; Pilowsky PM; Springell HJ; Pollard AC
    Lancet; 1979 Mar; 1(8118):688-90. PubMed ID: 85933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal diagnosis of neural-tube defects with a monoclonal antibody specific for acetylcholinesterase.
    Brock DJ; Barron L; van Heyningen V
    Lancet; 1985 Jan; 1(8419):5-8. PubMed ID: 2578203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quantitative acetylcholinesterase (AChE)--determination in amniotic fluid--potential for differential diagnosis in consistently high AFP levels during general AFP screening for prenatal diagnosis of open neural tube defects].
    Zwahr C; Grosch A; Horn A; Schulze M
    Zentralbl Gynakol; 1989; 111(19):1285-92. PubMed ID: 2480036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risks for fetal abnormalities after very and moderately elevated AF-AFPs.
    Crandall BF; Chua C
    Prenat Diagn; 1997 Sep; 17(9):837-41. PubMed ID: 9316128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biochemical markers of neural tube closure defects during the second half of pregnancy].
    Guibaud S; Boisson C; Simplot A; Thoulon JM
    J Genet Hum; 1988 Aug; 36(4):337-46. PubMed ID: 2464664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Routine amniotic fluid alphafetoprotein assay: experience with 40,000 pregnancies.
    Crandall BF; Matsumoto M
    Am J Med Genet; 1986 May; 24(1):143-9. PubMed ID: 2422932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal diagnosis of neural tube defects: experiences with acetylcholinesterase gel electrophoresis.
    Crandall BF; Kasha W; Matsumoto M
    Am J Med Genet; 1982 Jul; 12(3):361-6. PubMed ID: 6180640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. False-positive acetylcholinesterase with early amniocentesis.
    Burton BK; Nelson LH; Pettenati MJ
    Obstet Gynecol; 1989 Oct; 74(4):607-10. PubMed ID: 2797638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alphafetoprotein levels in amniotic fluid from 8 to 18 weeks of pregnancy.
    Wathen NC; Campbell DJ; Kitau MJ; Chard T
    Br J Obstet Gynaecol; 1993 Apr; 100(4):380-2. PubMed ID: 7684255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
    Widlund KF; Gottvall T
    Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. False-positive amniotic fluid acetylcholinesterase analysis in the third trimester.
    Suchy SF; Yeager MT
    Prenat Diagn; 1993 May; 13(5):363-9. PubMed ID: 8341634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter: Routine alpha-fetoprotein studies in amniotic fluid.
    Ainbender E; Hirschhorn K
    Lancet; 1976 Mar; 1(7959):597-8. PubMed ID: 55884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amniotic fluid cholinesterase measurement as a rapid method for the exclusion of fetal neural tube defects.
    Hullin DA; Elder GH; Laurence KM; Roberts A; Newcombe RG
    Lancet; 1981 Aug; 2(8242):325-7. PubMed ID: 6115109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.